Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

RevMAb

RevMAb
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$2.34M LATEST DEAL AMOUNT
Description

Owner and operator of a biotechnology company intended to focus on the development of recombinant monoclonal antibodies using a revolutionary technology. The company's antibodies promote personal health by accelerating biomedical research and advancing disease diagnosis without cell fusion and hybridoma generation, enabling clients to get superior monoclonal antibodies easily without generation of hybridoma.

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 870 Dubuque Avenue
  • South San Francisco, CA 94080
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore RevMAb’s full profile, request a free trial.

RevMAb Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 04-Feb-2018 $2.34M 00.000 Completed Startup
1. Angel (individual) 07-Apr-2016 00.00 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

RevMAb Executive Team (1)

Name Title Board
Seat
Contact
Info
Yaohuang Ke President, Chief Executive Officer & Board Member

RevMAb Board Members (3)

Name Representing Role Since Contact
Info
Dean Tsao RevMAb Board Member 000 0000
George Lee RevMAb Board Member 000 0000
Yaohuang Ke RevMAb President, Chief Executive Officer & Board Member 000 0000